Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.
Fabris E, Berta B, Hommels T, Roleder T, Hermanides RS, Rivero F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Roleder-Dylewska M, Gasior P, Malinowski KP, De Luca G, Garcia-Garcia HM, Granada JF, Wojakowski W, Kedhi E. Fabris E, et al. Among authors: de luca g. EuroIntervention. 2023 Feb 6;18(13):e1099-e1107. doi: 10.4244/EIJ-D-22-00306. EuroIntervention. 2023. PMID: 36170036 Free PMC article. Clinical Trial.
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
Camaro C, Damen SA, Brouwer MA, Kedhi E, Lee SW, Verdoia M, Barbieri L, Rognoni A, van T Hof AW, Ligtenberg E, de Boer MJ, Suryapranata H, De Luca G. Camaro C, et al. Among authors: de boer mj, de luca g. Am Heart J. 2016 Aug;178:37-44. doi: 10.1016/j.ahj.2016.04.016. Epub 2016 Apr 29. Am Heart J. 2016. PMID: 27502850 Clinical Trial.
Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial.
Schoos MM, De Luca G, Dangas GD, Clemmensen P, Ayele GM, Mehran R, Stone GW. Schoos MM, et al. Among authors: de luca g. EuroIntervention. 2016 Oct 20;12(9):1144-1153. doi: 10.4244/EIJV12I9A186. EuroIntervention. 2016. PMID: 27753600 Free article. Clinical Trial.
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials.
De Luca G, Smits P, Hofma SH, Di Lorenzo E, Vlachojannis GJ, Van't Hof AWJ, van Boven AJ, Kedhi E, Stone GW, Suryapranata H; Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation. De Luca G, et al. Int J Cardiol. 2017 Oct 1;244:121-127. doi: 10.1016/j.ijcard.2017.06.022. Epub 2017 Jun 13. Int J Cardiol. 2017. PMID: 28673736 Review.
Corrigendum to "Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials" [Int. J. Cardiol. 264 (2018) 30-38].
Verdoia M, Kedhi E, Ceccon C, Suryapranata H, De Luca G. Verdoia M, et al. Among authors: de luca g. Int J Cardiol. 2018 Nov 15;271:407. doi: 10.1016/j.ijcard.2018.06.016. Epub 2018 Aug 23. Int J Cardiol. 2018. PMID: 30146247 No abstract available.
1,608 results